ClinicalTrials.gg
Not yet recruitingNCT06053151Updated Sep 25, 2023

Cloud Platform Integration Model for Pregnant Women Exercise Consultation

An interventional study of exercise counselling in Exercise and Pregnancy Related, sponsored by Mackay Medical College. Not yet recruiting. Open to female participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-25.

Sponsored by Mackay Medical College · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
Female
01

Study summary

To construct the platform for exercise counseling for pregnant women, and evaluate the effects of that telecare platform integration model for exercise consultation on exercise behaviors and prenatal health outcomes among pregnant women during pregnancy.

Read the detailed description

This study will develop and construct an exercise counseling model with using cloud platform for women during pregnancy. In addition, we will evaluate the effects of that telecare platform integration model for exercise consultation on exercise behaviors and prenatal health outcomes among pregnant women during pregnancy.

02

Conditions studied

  • Exercise
  • Pregnancy Related

Browse trials for

Keywords

  • exercise counselling
  • pregnancy
  • women
  • platform
  • physical activity
03

In context

Motor Activity

9,824 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

This study's planned enrollment of 154 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Mackay Medical College is the lead sponsor of 20 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant women who less than 17 gestation and able to understand basic technologies such as smartphone and computer

Exclusion criteria

Exclusion Criteria:

  • women who had a diagnosis of pregnancy related compliactions and absolute limited exercise, such as preterm contraction, ruputer of menbrance, evidence of intrauterus growth retardation, heart and lung disease, cervical incompetence and/or medical conditions that influence exercise.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
154 participants (estimated)

Study arms

  • Experimental
    experiemental group

    The experimental group will receive the cloud platform integration model for exercise consultation intervention for two phases continue 24 weeks to promote exercise behavior during pregnancy.

    Behavioral: exercise counselling

  • No intervention
    control group

    The control group will receive standard antenatal treatments without intervention.

Interventions

  • Behavioralexercise counselling

    . The experimental group will receive the cloud platform integration model for exercise consultation intervention for two phases continue 24 weeks to promote exercise behavior during pregnancy. The goal of the first phase was to start regular exercise, and the goal of the second phase was to continue regular exercise.

06

What researchers measure

Primary outcomes

  1. increase physiacl activity

    measure by pregnancy physical activity questionnaire

    Time frame: The data were collected before the intervention to childbirth: <16 week gestation, second trimester (24-26 weeks) and third trimester (34-36 weeks)

  2. decrese symptom distress

    pregnancy related symptom distress scale

    Time frame: The data were collectedbefore the intervention to childbirth: <16 week gestation, second trimester (24-26 weeks) and third trimester (34-36 weeks)

  3. decrease pregnancy related complications

    such as gestational diabetes, pregancy related hypertension, preclampsia, preterm labor.

    Time frame: The data were collectedbefore the intervention to childbirth: <16 week gestation, second trimester (24-26 weeks) and third trimester (34-36 weeks)

Secondary outcomes

  1. construct exercise counseling model

    intergrate the could platform in exercise counseling for pregnant women

    Time frame: The data will be collected from pregnant women and experts perspectives; From date of first participant attend the focus group until the date of the last experts meeting , assessed up to 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2023; primary completion for May 2024, 5 months later.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 5 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2023
First posted
Sep 25, 2023
StartEst.
Dec 15, 2023
Primary completionEst.
May 31, 2024
CompletionEst.
Jul 31, 2025
Last update
Sep 25, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06053151
Lead sponsor
Mackay Medical College
Responsible party
Chin-Tsung Shen (head of administion, Mackay Medical College) — Principal investigator
First posted
Sep 25, 2023
Start date
Dec 15, 2023 (estimated)
Primary completion
May 31, 2024 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Sep 25, 2023

Study contacts

Ching Fang Lee, PhD
Contact
chingfang@mmc.edu.tw
+886 26360323 ext. 1323
Ching Fang Lee, PhD
principal investigator · Mackay Medical College

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion